← SynDRA
RESMETIROM
SynDRA canonical compound SYN0038009 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | THRB |
|---|
| Mechanism of action | thyroid hormone receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- THRB AGONIST
- Thyroid hormone receptor beta-1 agonist
- THRA AGONIST
- thyroid hormone receptor agonist
Cross-references
Synonyms
- MGL-3196
- Rezdiffra
- VIA-3196
- MGL 3196
- RE0V0T1ES0
- resmetiromum
- RefChem:879457
- Resmetirom [USAN]
- MFCD26142653
- Resmetirom (MGL-3196)
- UNII-RE0V0T1ES0
- C17H12Cl2N6O4
- FDBYIYFVSAHJLY-UHFFFAOYSA-N
- Rezdiffra (TN)
- Resmetirom [WHO-DD]
- RESMETIROM [INN]
- Resmetirom (USAN/INN)
- MGL-3196(Resmetirom)?
- orb1304018
- SCHEMBL2927241
- SCHEMBL28555674
- GTPL12026
- VIA3196
- GLXC-10714
- HMS3746A03
- EX-A2477
- VLB50932
- BDBM50012905
- s6663
- WHO 10850
- AKOS032945066
- CS-6179
- SB16825
- compound 53 [PMID: 24712661]
- AC-31458
- BS-17855
- HY-12216
- SY289460
- DB-127167
Look up RESMETIROM in the interactive SynDRA portal →